Article Versions Notes

Sankaranarayanan R, Valiveti CK, Kumar DR, Van slambrouck S, Kesharwani SS, Seefeldt T, Scaria J, Tummala H, Bhat GJ. The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention. Cancers. 2019; 11(3):427. https://doi.org/10.3390/cancers11030427

Sankaranarayanan, Ranjini, Chaitanya K. Valiveti, D. Ramesh Kumar, Severine Van slambrouck, Siddharth S. Kesharwani, Teresa Seefeldt, Joy Scaria, Hemachand Tummala, and G. Jayarama Bhat. 2019. "The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention" Cancers 11, no. 3: 427. https://doi.org/10.3390/cancers11030427

Sankaranarayanan, R., Valiveti, C. K., Kumar, D. R., Van slambrouck, S., Kesharwani, S. S., Seefeldt, T., Scaria, J., Tummala, H., & Bhat, G. J. (2019). The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention. Cancers, 11(3), 427. https://doi.org/10.3390/cancers11030427